|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||





,


,

,
* Department of Thoracic Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan; and Departments of
Medicine,
Microbiology and Immunology, and
Pathology, Indiana University School of Medicine, Indianapolis, IN 46202
We have reported that lung allograft rejection involves an immune
response to a native protein in the lung, type V collagen (col(V)), and
that col(V)-induced oral tolerance prevented acute and chronic
rejection. In support of these findings col(V) fragments were detected
in allografts during rejection, but not in normal lungs. The purpose of
the current study was to isolate and characterize col(V)-specific
allograft-infiltrating T cells and to determine their contribution to
the rejection response in vivo. Two col(V)-specific T cell lines, LT1
and LT3, were isolated from F344 (RT1lv1) rat lung
allografts during rejection that occurred after transplantation into
WKY (RT1l) recipients. Both cell lines, but not normal lung
lymphocytes, proliferated in response to col(V). Neither LT1 nor LT3
proliferated in response to alloantigens. LT1 and LT3 were
CD4+CD25- and produced IFN-
in response to
col(V). Compared with normal CD4+ T cells, both cell lines
expressed a limited V-
TCR repertoire. Each cell strongly expressed
V-
9 and 16, but differed in expression of other V-
s. Adoptive
transfer of each cell line did not induce pathology in lungs of normal
WKY rats. In contrast, adoptive transfer of LT1, but not LT3, caused
marked peribronchiolar and perivascular inflammation in isograft (WKY)
lungs and abrogated col(V)-induced oral tolerance to allograft (F344)
lungs. Collectively, these data show that lung allograft rejection
involves both allo- and autoimmune responses, and graft destruction
that occurs during the rejection response may expose
allograft-infiltrating T cells to potentially antigenic epitopes in
col(V).
This article has been cited by other articles:
![]() |
M. T. Hardison, F. S. Galin, C. E. Calderon, U. V. Djekic, S. B. Parker, K. M. Wille, P. L. Jackson, R. A. Oster, K. R. Young, J. E. Blalock, et al. The Presence of a Matrix-Derived Neutrophil Chemoattractant in Bronchiolitis Obliterans Syndrome after Lung Transplantation J. Immunol., April 1, 2009; 182(7): 4423 - 4431. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Belperio, S. S. Weigt, M. C. Fishbein, and J. P. Lynch III Chronic Lung Allograft Rejection: Mechanisms and Therapy Proceedings of the ATS, January 15, 2009; 6(1): 108 - 121. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Fukami, S. Ramachandran, D. Saini, M. Walter, W. Chapman, G. A. Patterson, and T. Mohanakumar Antibodies to MHC Class I Induce Autoimmunity: Role in the Pathogenesis of Chronic Rejection J. Immunol., January 1, 2009; 182(1): 309 - 318. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Iwata, A. Philipovskiy, A. J. Fisher, R. G. Presson Jr., M. Chiyo, J. Lee, E. Mickler, G. N. Smith, I. Petrache, D. B. Brand, et al. Anti-Type V Collagen Humoral Immunity in Lung Transplant Primary Graft Dysfunction J. Immunol., October 15, 2008; 181(8): 5738 - 5747. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Bobadilla, R. B. Love, E. Jankowska-Gan, Q. Xu, L. D. Haynes, R. K. Braun, M. S. Hayney, A. Munoz del Rio, K. Meyer, D. S. Greenspan, et al. Th-17, Monokines, Collagen Type V, and Primary Graft Dysfunction in Lung Transplantation Am. J. Respir. Crit. Care Med., March 15, 2008; 177(6): 660 - 668. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Mahesh, H.-S. Leong, A. McCormack, P. Sarathchandra, A. Holder, and M. L. Rose Autoantibodies to Vimentin Cause Accelerated Rejection of Cardiac Allografts Am. J. Pathol., April 1, 2007; 170(4): 1415 - 1427. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Daud, R. D. Yusen, B. F. Meyers, M. M. Chakinala, M. J. Walter, A. A. Aloush, G. A. Patterson, E. P. Trulock, and R. R. Hachem Impact of Immediate Primary Lung Allograft Dysfunction on Bronchiolitis Obliterans Syndrome Am. J. Respir. Crit. Care Med., March 1, 2007; 175(5): 507 - 513. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bharat, R. C. Fields, E. P. Trulock, G. A. Patterson, and T. Mohanakumar Induction of IL-10 Suppressors in Lung Transplant Patients by CD4+25+ Regulatory T Cells through CTLA-4 Signaling J. Immunol., October 15, 2006; 177(8): 5631 - 5638. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Wilkes, T. M. Egan, and H. Y. Reynolds Lung Transplantation: Opportunities for Research and Clinical Advancement Am. J. Respir. Crit. Care Med., October 15, 2005; 172(8): 944 - 955. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Ponticelli Renal transplantation 2004: where do we stand today? Nephrol. Dial. Transplant., December 1, 2004; 19(12): 2937 - 2947. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. L. Sumpter and D. S. Wilkes Role of autoimmunity in organ allograft rejection: a focus on immunity to type V collagen in the pathogenesis of lung transplant rejection Am J Physiol Lung Cell Mol Physiol, June 1, 2004; 286(6): L1129 - L1139. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Swanson, Y. Zheng, K. M. Heidler, T. Mizobuchi, and D. S. Wilkes CDllc+ Cells Modulate Pulmonary Immune Responses by Production of Indoleamine 2,3-Dioxygenase Am. J. Respir. Cell Mol. Biol., March 1, 2004; 30(3): 311 - 318. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Mizobuchi, K. Yasufuku, Y. Zheng, M. A. Haque, K. M. Heidler, K. Woods, G. N. Smith Jr., O. W. Cummings, T. Fujisawa, J. S. Blum, et al. Differential Expression of Smad7 Transcripts Identifies the CD4+CD45RChigh Regulatory T Cells That Mediate Type V Collagen-Induced Tolerance to Lung Allografts J. Immunol., August 1, 2003; 171(3): 1140 - 1147. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |